Budge et al. reported that the transgenic overexpression of GPNMB reduced gliosis, prevented morphological changes in the microglia, and protected against dopaminergic neurodegeneration in the PD mouse model [49]. This evidence concerns the gene GPNMB and Parkinson disease.